United Health Products Inc. Stock Analysis UEEC

United Health Products, Inc. engages in the development, manufacture, and marketing of wound care products based on its proprietary hemostatic gauze technology. The company is headquartered in Mount Laurel, New Jersey and currently employs 2 full-time employees. The company went IPO on 2007-02-14. Its gauze product, HemoStyp, is derived from cotton and designed to absorb exudate/drainage from superficial wounds and help control bleeding. CelluSTAT hemostatic gauze is a flexible, silk-like material that is applied by placing the gauze onto the bleeding tissue. The supple material can be easily folded and manipulated as needed to fit the size of the wound or incision. In surface bleeding and surgical situations, the product quickly converts to a translucent gel that allows the physician or surgeon to monitor the coagulation process. In superficial bleeding situations, HemoStyp can be bonded to an adhesive plastic bandage or integrated into a traditional gauze component to address a range of needs, including traumatic bleeding injuries and prolonged bleeding following hemodialysis. Its customer base includes hospitals, surgery centers, clinics, and others.